Large-scale chemical–genetics yields new inhibitor classes

Journal: Nature

Published: 2019-06-19

DOI: 10.1038/s41586-019-1315-z

Affiliations: 18

Authors: 44

Go to article
Institutions Share
Broad Institute of MIT and Harvard, United States of America (USA) 0.37
Department of Microbiology and Immunology, Cornell University, United States of America (USA) 0.22
Harvard Department of Immunology and Infectious Diseases, United States of America (USA) 0.13
Department of Microbiology and Physiological Systems (MaPS), UMass Medical School, United States of America (USA) 0.10
Department of Electrical and Computer Engineering, TAMU, United States of America (USA) 0.02
Center for Computational and Integrative Biology (CCIB), MGH, United States of America (USA) 0.02
Harvard Department of Genetics, United States of America (USA) 0.02
Department of Molecular Biology, MGH, United States of America (USA) 0.02
Regulatory and Quality Solutions LLC (R&Q), United States of America (USA) 0.01
Caribou Biosciences, Inc., United States of America (USA) 0.01
Yale School of Medicine (YSM), United States of America (USA) 0.01
School of Medicine (BUSM), BU, United States of America (USA) 0.01
Rush University Medical Center, United States of America (USA) 0.01
Regeneron Pharmaceuticals, Inc., United States of America (USA) 0.01
School of Medicine, SLU, United States of America (USA) 0.01
Stanford Department of Biochemistry, United States of America (USA) 0.01
Harvard Biological and Biomedical Sciences (BBS) Progam, United States of America (USA) 0.01
College of Information and Computer Sciences, UMass Amherst, United States of America (USA) 0.01

Return